Twist Bioscience Corp (TWST) Stock Analysis

Verdict: AVOID

Extreme technical extension and heavy insider selling signal a price-value disconnect despite strong 52% gross margins and revenue growth.

Investment score: 38/100

Analysis as of

Is Twist Bioscience Corp stock worth reviewing? The TradeMates thesis

Twist Bioscience is currently trading in 'bubble' territory relative to its fundamentals and analyst targets. While the company's DNA synthesis technology is market-leading, the combination of persistent losses, aggressive insider selling at prices 12% lower than current levels, and a 22% single-day spike without a fundamental catalyst creates a high-risk entry point.

7-factor investment score

Twist Bioscience Corp opportunities and risks

What speaks for TWST

What speaks against TWST

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
TWSTn/a20.5xn/a52.0%-31.7%-1.1%
IONSn/a11.6x2.8x98.2%-64.6%-5.5%
PTGX127.2x35.3x111.8x99.9%29.4%1.3%
SYREn/a104.5xn/a0.0%-197.7%-2.2%
PCVXn/a0.0xn/a0.0%0.0%-13.2%
IMVTn/a1307.9xn/a97.1%-7585.9%-4.5%
Peer mediann/a35.3xn/a97.1%-64.6%-4.5%

Frequently asked questions about Twist Bioscience Corp (TWST)

Is TWST stock a good investment?

The TradeMates model rates Twist Bioscience Corp as AVOID with an investment score of 38/100. Twist Bioscience is currently trading in 'bubble' territory relative to its fundamentals and analyst targets. While the company's DNA synthesis technology is market-leading, the combination of persistent losses, aggressive insider selling at prices 12% lower than current levels, and a 22% single-day spike without a fundamental catalyst creates a high-risk entry point. This is algorithmic model output, not personal investment advice.

Is TWST stock a buy?

The TradeMates model verdict for TWST is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.